Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Research Advisory Committee on Gulf War Veterans' Illnesses


Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge

Research Update - November 2005


The following journal articles were distributed for review in November 2005.  You can access the article's abstract by copying the paper title and pasting it into the search bar of the PubMed website, linked here. 

Research Relevant to Gulf War Service and Exposures
1. Q fever and the US military.  (Anderson  AD, et al.  Emerg Infect Dis.  Aug 2005; 11(8): 1320-1322)
2. An observational study on diagnoses of 3,233 Gulf Veterans (Op Granby 1990-91) who attended the Ministry of Defence’s Medical Assessment Programme 1993-2004.  (Bale AJ, Lee HA.  J R Nav Med Serv.  2005; 91(2): 99-11
3. Toxic serum factor long after single exposure to organophosphate: a new approach for biomonitoring.  (Berman-Shlomovich T, et al.  Arch Toxicol.  Oct 20, 2005; 1-6 [Epub ahead of print])
4. Chronic Multisymptom illness complex in Gulf War I veterans 10 years later.  (Blanchard MS, et al.  Am J Epidemiol.  Nov 17, 2005 [Epub ahead of print])
5. Neurodegenerative diseases: an overview of environmental risk factors.  (Brown RC, et al.  Environ Health Perspect.  Sep 2005; 113(9): 1250-1256)
6. Postural stability index is a more valid measure of stability than equilibrium score.  (Chaudhry H, et al.   J Rehabil Res Dev.  Jul-Aug 2005; 42(4): 547-556)
7. The Veterans Affairs research program: scientific and clinical excellence relevant to veterans’ healthcare needs.  (Cheadle WG.  Am J Surg.  Nov 2005; 190(5): 655-661)
8.¬†Tribunal declares Gulf war syndrome an ‚Äúumbrella term.‚Ä̬† (Dyer O.¬† BMJ.¬† Nov 12, 2005; 331(7525): 1103)
9. The chemical operation of uranium in water does not influence its absorption from the gastrointestinal tract of rats.  (Frelon S, et al.  Chem Res Toxicol.  Jul 2005; 18(7): 1150-1154)
10. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat.  (Gueguen Y, et al.  Arch Toxicol.  Oct 18, 2005; 1-9 [Epub ahead of print])
11. War zone stress without direct combat: The Australian naval experience of the Gulf War.  (Ikin JF, et al.  J Trauma Stress.  Jun 2005; 18(3): 193-204)
12. What happens to British veterans when they leave the armed forces?  (Iversen A, et al.  Eur J Public Health.  Apr 2005; 15(2): 175-84)
13. Changes in sleep-wake cycle after chronic exposure to uranium in rats.  (Lestaevel P, et al.  Neurotoxicol Teratol.  Aug 11, 2005; [Epub ahead of print])
14. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.  (Li B, et al.  Biochem Pharmacol.  Oct 4, 2005; [Epub ahead of print])
15. [Inducible nitric oxide synthase gene expression in the testis of rats instilled with depleted uranium particles.]  (Li JS, et al.  Zhonghua Nan  Ke Xue.  Sep 2005; 11(9): 655-657) [Note: Non-English language publication]
16. Long-term mortality amongst Gulf War Veterans: is there a relationship with experiences during deployment and subsequent morbidity?  (Macfarlane GJ, et al.  Int J Epidemiol.  Oct 26, 2005; [Epub ahead of print])
17. Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans.  (Mahmoudi M, et al.  Int Immunopharmacol.  Aug 2005; 5(9): 1479-1485)
18. Informed consent and ethical issues in military medical research.  (McManus J, et al.  Acad Emerg Med.  Nov 2005; 12(11): 1120-1126)
19. Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium.  (Miller AC, et al.  Mol Cell Biochem .  Nov 2005; 279(1-2): 97-104)
20. Genotoxic and inflammatory effects of depleted uranium particles inhaled by rats.  (Monleau M, et al.  Toxicol Sci.  Oct 12, 2005; [Epub ahead of print])
21. Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.  (Rijpkema SG, et al.  Hum Vaccines.  Jul-Aug 2005; 1(4): 165-169)
22. Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan).  (Sanders JW, et al.  Am J Trop Med Hyg.  Oct 2005; 73(4): 713-719)
23. Human serum butyrylcholinesterase: In vitro and in vivo stability, pharmacokinetics, and safety in mice.  (Saxena A, et al.  Chem Biol Interact.  Oct 28, 2005; [Epub ahead of print])
24. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents.  (Shih TM, et al.  Chem Biol Interact.  Oct 24, 2005; [Epub ahead])
25. Correlates for posttraumatic stress disorder in Gulf War veterans: a retrospective study of main and moderating effects.  (Stein Al, et al.  J Anxiety Disord.  2005; 19(8): 861-876)
26. Expression of cholinesterase in brain and non-brain tumors.  (Vidal CJ.  Chem Biol Interact.  Oct 25, 2005; [Epub ahead of print])
27. Deployment stressors, gender, and mental health outcomes among Gulf War I veterans.  (Vogt DS, et al.  J Trauma Stress.  Apr 2005; 18(2): 115-127)
28.¬†Erratum: D.S. Vogt, A.P. Bless, L.A. King, and D.W. King. ‚ÄėDeployment stressors, gender, and mental health outcomes among Gulf War I veterans‚Äô.¬† Journal of Traumatic Stress 18(2) 2005, 115-127.¬† (Vogt DS, et al.¬† J Trauma Stress.¬† Jun 2005; 18(3): 271-284)

Research Relevant to Evaluation/Treatment of Chronic Multisymptom Ilnesses
1. Relieving fibromyalgia pain. An epilepsy medication and a popular cough syrup both seem to work.  ([No authors listed].  Health News.  Sep 2005; 11(9): 14-15)
2. Rehabilitation approaches in fibromyalgia.  (Adams N, Sim J.  Disabil Rehabil.  Jun 17, 2005; 27(12): 711-723)
3. Fibromyalgia: Progress in diagnosis and treatment.  (Dadabhoy D, Clauw DJ.  Curr Pain Headache Rep.  Dec 2005; 9(6): 399-404)
4. Physiologic and symptomatic responses to low-level substances in individuals with and without chemical sensitivities: a randomized controlled blinded pilot booth study.  (Joffres MR, et al.  Environ Health.  Sep 2005; 113(9): 1178-1183)
5. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in Chronic Fatigue Syndrome (CFS): Relevance for the inflammatory response in CFS.  (Maes M, et al.  Neuro Endocrinol.  Oct 30, 2005; 26(5): [Epub ahead of print])
6. Exercise prescription for individuals with chronic fatigue syndrome.   (Wallman KE, et al.  Med J Aust.  Aug 1, 2005; 183(3): 142-143)

Back to Previous Research Updates